美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
72865-233-05	72865-233	HUMAN PRESCRIPTION DRUG	Methocarbamol	Methocarbamol	TABLET	ORAL	20240202	N/A	ANDA	ANDA090200	XLCare Pharmaceuticals Inc.	METHOCARBAMOL	500 mg/1	500 TABLET in 1 BOTTLE (72865-233-05)
72865-233-01	72865-233	HUMAN PRESCRIPTION DRUG	Methocarbamol	Methocarbamol	TABLET	ORAL	20240202	N/A	ANDA	ANDA090200	XLCare Pharmaceuticals Inc.	METHOCARBAMOL	500 mg/1	100 TABLET in 1 BOTTLE (72865-233-01)
72865-234-05	72865-234	HUMAN PRESCRIPTION DRUG	Methocarbamol	Methocarbamol	TABLET	ORAL	20240202	N/A	ANDA	ANDA090200	XLCare Pharmaceuticals Inc.	METHOCARBAMOL	750 mg/1	500 TABLET in 1 BOTTLE (72865-234-05)
61919-903-90	61919-903	HUMAN PRESCRIPTION DRUG	METHOCARBAMOL	METHOCARBAMOL	TABLET	ORAL	20190423	N/A	ANDA	ANDA090200	DirectRX	METHOCARBAMOL	750 mg/1	90 TABLET in 1 BOTTLE (61919-903-90)
61919-903-72	61919-903	HUMAN PRESCRIPTION DRUG	METHOCARBAMOL	METHOCARBAMOL	TABLET	ORAL	20190829	N/A	ANDA	ANDA090200	Direct_Rx	METHOCARBAMOL	750 mg/1	120 TABLET in 1 BOTTLE (61919-903-72)
61919-903-30	61919-903	HUMAN PRESCRIPTION DRUG	METHOCARBAMOL	METHOCARBAMOL	TABLET	ORAL	20190827	N/A	ANDA	ANDA090200	Direct_Rx	METHOCARBAMOL	750 mg/1	30 TABLET in 1 BOTTLE (61919-903-30)
61919-903-40	61919-903	HUMAN PRESCRIPTION DRUG	METHOCARBAMOL	METHOCARBAMOL	TABLET	ORAL	20190829	N/A	ANDA	ANDA090200	Direct_Rx	METHOCARBAMOL	750 mg/1	40 TABLET in 1 BOTTLE (61919-903-40)
61919-903-60	61919-903	HUMAN PRESCRIPTION DRUG	METHOCARBAMOL	METHOCARBAMOL	TABLET	ORAL	20190829	N/A	ANDA	ANDA090200	Direct_Rx	METHOCARBAMOL	750 mg/1	60 TABLET in 1 BOTTLE (61919-903-60)
50090-0182-0	50090-0182	HUMAN PRESCRIPTION DRUG	Methocarbamol	Methocarbamol	TABLET	ORAL	20141128	N/A	ANDA	ANDA090200	A-S Medication Solutions	METHOCARBAMOL	500 mg/1	40 TABLET in 1 BOTTLE (50090-0182-0)
50090-0182-4	50090-0182	HUMAN PRESCRIPTION DRUG	Methocarbamol	Methocarbamol	TABLET	ORAL	20141128	N/A	ANDA	ANDA090200	A-S Medication Solutions	METHOCARBAMOL	500 mg/1	30 TABLET in 1 BOTTLE (50090-0182-4)
50090-0182-5	50090-0182	HUMAN PRESCRIPTION DRUG	Methocarbamol	Methocarbamol	TABLET	ORAL	20141128	N/A	ANDA	ANDA090200	A-S Medication Solutions	METHOCARBAMOL	500 mg/1	14 TABLET in 1 BOTTLE (50090-0182-5)
50090-0182-8	50090-0182	HUMAN PRESCRIPTION DRUG	Methocarbamol	Methocarbamol	TABLET	ORAL	20200812	N/A	ANDA	ANDA090200	A-S Medication Solutions	METHOCARBAMOL	500 mg/1	56 TABLET in 1 BOTTLE (50090-0182-8)
50090-0183-0	50090-0183	HUMAN PRESCRIPTION DRUG	Methocarbamol	Methocarbamol	TABLET	ORAL	20160621	N/A	ANDA	ANDA090200	A-S Medication Solutions	METHOCARBAMOL	500 mg/1	10 TABLET in 1 BOTTLE (50090-0183-0)
50090-0183-2	50090-0183	HUMAN PRESCRIPTION DRUG	Methocarbamol	Methocarbamol	TABLET	ORAL	20141128	N/A	ANDA	ANDA090200	A-S Medication Solutions	METHOCARBAMOL	500 mg/1	7 TABLET in 1 BOTTLE (50090-0183-2)
50090-0183-4	50090-0183	HUMAN PRESCRIPTION DRUG	Methocarbamol	Methocarbamol	TABLET	ORAL	20141128	N/A	ANDA	ANDA090200	A-S Medication Solutions	METHOCARBAMOL	500 mg/1	90 TABLET in 1 BOTTLE (50090-0183-4)
50090-0184-0	50090-0184	HUMAN PRESCRIPTION DRUG	Methocarbamol	Methocarbamol	TABLET	ORAL	20141128	N/A	ANDA	ANDA090200	A-S Medication Solutions	METHOCARBAMOL	500 mg/1	40 TABLET in 1 BOTTLE (50090-0184-0)
50090-0182-1	50090-0182	HUMAN PRESCRIPTION DRUG	Methocarbamol	Methocarbamol	TABLET	ORAL	20160621	N/A	ANDA	ANDA090200	A-S Medication Solutions	METHOCARBAMOL	500 mg/1	20 TABLET in 1 BOTTLE (50090-0182-1)
50090-0182-2	50090-0182	HUMAN PRESCRIPTION DRUG	Methocarbamol	Methocarbamol	TABLET	ORAL	20200812	N/A	ANDA	ANDA090200	A-S Medication Solutions	METHOCARBAMOL	500 mg/1	80 TABLET in 1 BOTTLE (50090-0182-2)
50090-0182-3	50090-0182	HUMAN PRESCRIPTION DRUG	Methocarbamol	Methocarbamol	TABLET	ORAL	20141128	N/A	ANDA	ANDA090200	A-S Medication Solutions	METHOCARBAMOL	500 mg/1	60 TABLET in 1 BOTTLE (50090-0182-3)
67296-1049-3	67296-1049	HUMAN PRESCRIPTION DRUG	Methocarbamol	Methocarbamol	TABLET	ORAL	20130320	N/A	ANDA	ANDA090200	RedPharm Drug, Inc.	METHOCARBAMOL	750 mg/1	30 TABLET in 1 BOTTLE (67296-1049-3)